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Classical swine fever (CSF) is an endemic disease in many countries. A key tool for
laboratory confirmation of CSF is a differential diagnosis between vaccinated and actually infected
pigs. Many enzyme-linked immunosorbent assays (ELISA) are based on the capture of antibodies in
animal sera, but these tests cannot be used in animals that are persistently infected. In these cases, an
antigen-capture ELISA may be a good choice to differentiate vaccinated animals from those that are
infected. In order to produce a polyclonal antibody that allows this technique, two rabbits were
immunized with recombinant Erns protein. The antibody was conjugated to horseradish peroxidase
(HRP) and the optimal working dilution was 1:64 000 in a direct ELISA. Different coating conditions
were evaluated to trap recombinant Erns in a sandwich ELISA and it was concluded that coating at
10 μg/mL would ensure greater capture. The ELISA was able to detect Erns from a mixture of sera
from pigs vaccinated with the Chinese strain of classical swine fever virus (CSFV). In addition, no
reaction was observed in sera from healthy animals or in sera from animals vaccinated with Porvac®,
an E2 protein subunit vaccine. It was concluded that the generated polyclonal antibody can recognize
the viral Erns protein in pig sera, so it could be used in a sandwich ELISA to differentiate healthy
animals from those infected with CSFV.
anti-Erns polyclonal antibody, CSFV, ELISA.
La peste porcina clásica (PPC) es una enfermedad endémica en numerosos países. Una
herramienta clave para la confirmación en laboratorio de la PPC es el diagnóstico diferencial entre
cerdos vacunados y los que están realmente infectados. Muchos ensayos inmunoadsorbentes ligados a
enzima (ELISA) están basados en la captura de anticuerpos en los sueros, pero estos ensayos no
pueden utilizarse en aquellos animales que están persistentemente infectados. En tales casos, un
ELISA de captura de antígeno podría ser una buena elección para diferenciar los animales vacunados
de aquellos que están infectados. Con el objetivo de producir un anticuerpo policlonal que permita esta
técnica, se inmunizaron dos conejos con proteína Erns recombinante. El anticuerpo fue conjugado a
peroxidasa de rábano picante (HRP) y la dilución óptima de trabajo fue de 1:64 000 en un ELISA
directo. Se evaluaron diferentes condiciones de recubrimiento para atrapar Erns recombinante en un
ELISA y se concluyó que el recubrimiento a 10 μg/mL aseguraría mayor captura. En el ELISA se
pudo detectar la Erns de una mezcla de sueros de cerdos vacunados con la cepa china del virus de la
peste porcina clásica (VPPC). Además, no se observó reacción en sueros de animales sanos ni con
sueros de animales vacunados con Porvac®, vacuna de subunidad basada en la glicoproteína E2. Se
concluyó que el anticuerpo policlonal generado puede reconocer la proteína Erns viral en sueros
porcinos y que podría ser utilizado en un ELISA sándwich para el diagnóstico de la PPC, en aquellos
animales persistentemente infectados o inmunodeprimidos.
anticuerpo policlonal anti-Erns, VPPC, ELISA.
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INTRODUCTION
CSF is highly contagious viral disease
affecting domestic pigs and wild boar. It is
endemic in several South and Central American
countries, in the Caribbean region, as well as in
Asia, and in some Eastern European countries
(1). The economic and social consequences of its
impact place CSF on the list of notifiable
diseases for the World Organization for Animal
Health (2). Its etiologic agent is CSFV, an
enveloped virus with a single plus strand RNA
genome, included on the genus Pestivirus in the
Flaviviridae family (3).
The serological analysis is a very used tool for
the diagnosis of CSF (4). However, pigs born
from vaccinated mothers may present anti-CSF
antibodies by passive immunity. This, although
giving them clinical protection, does not imply
that animals are free from infection (5). In
addition, persistently infected pigs with low or
moderate virulent CSF isolate do not develop
immune response, even when they shed high
viral load in their excretion (6). Reverse
transcription-polymerase chain reaction (RT-
PCR) assay is the best tool available for the
diagnosis of CSF (4), but this technique could be
costly in many countries. Hence, ELISA antigen
tests could be a useful and easily performed tool
for this purpose.
Currently there are numerous ELISAs to detect
viruses and antibodies to evaluate the
effectiveness of developed vaccines.
Glycoproteins E2 and Erns are among the most
immunogenic proteins of CSFV, both of them are
candidates for the development of a DIVA
vaccination system (7). The glycoprotein Erns is
the second most immunogenic within the viral
envelope, and it is able to induce a neutralizing
antibody response, which explains its use as an
attractive protein for the immunological
diagnosis of infection by CSFV (1). The
available ELISA tests in the market are expensive
to monitor CSFV in developing countries (8). An
anti-Erns antibody that allows the development
of an ELISA to capture Erns in samples from
infected animals is advantageous for the
differential diagnosis of CSF as accompanying
test to E2 marker vaccine. This would ensure in
the diagnosis of animals to differentiate among
the immunized, the infected and the healthy.
Therefore, the aim of this work is to produce a
polyclonal antibody capable of recognizing viral
Erns in pig sera.
MATERIALS AND METHODS
Purification of Erns antigen
The protein was extracted from Escherichia
coli BL21 DE3 cells transformed with pET22b-
Erns, which expressed a truncated form of Erns
fused to a 6-histidine tag at the C-terminal end
and to pelb leader sequence by the N-terminal
end. Chromatography was performed by metal
chelate affinity chromatography (IMAC) under
denaturing conditions, using 6.5 mL of Chelating
Sepharose TM Fast Flow matrix charged with Ni2+
and packed in a C10/10 column (GE Healthcare).
The column was equilibrated with binding buffer
(20 mM Tris-HCl, 200 mM NaCl, 2 mM
Imidazole, 8 M Urea, pH 6) at a volumetric flow
rate of 0.6 mL/min. Purification processes
included a washing with 50 mM Imidazole, and
protein elution was performed with 200 mM
Imidazole.
SDS-PAGE
Protein electrophoresis was performed on a
12 % polyacrylamide denaturing gel with 2 %
Sodium Dodecyl Sulfate (SDS). Samples were
diluted in loading buffer (125 mM Tris-HCl, pH
6.8, 1 % (w/v) SDS, 5 % (v/v) glycerol, 10 mM
Dithiothreitol, 0,005 % (w/v) Blue Bromophenol)
and boiled for 10 minutes. The samples were run
for about 45 minutes at a constant voltage of
200 V in running buffer (25 mM Tris-HCl, pH
8.8; 192 mM Glycine; 35 mM SDS). The gel was
stained with a 0.1 % (w/v) Coomassie R-250
solution, 40 % (v/v) methanol, 10 % (v/v) acetic
acid for 20 minutes and the bands were
visualized after gel destaining with a 10 % (v/v)
methanol and 10 % (v/v) acetic acid.
Detection of proteins by western blotting
For western blotting assay, proteins were
transferred (100 V, for 1 h) from the
polyacrylamide gel to a PVDF membrane (Roche
Diagnostics, Germany). As the primary antibody,
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the purified anti-Erns polyclonal antibody was
used (5 μg/mL) in skimmed milk powder (1 %) -
PBS-1X-Tween 20 (0.05 %). As the secondary
antibody, an anti- rabbit IgG conjugated to
alkaline phosphatase diluted 1: 20000 (Sigma
Aldrich, USA) was used. Colorimetric detection
was performed with 5-bromo-4-dichloro-indolyl
phosphate and nitroblue tetrazolium (Promega,
USA).
Immunization of rabbits with Erns
antigen
Two white New Zealand male rabbits
weighing approximately 1.5 kg, supplied by the
National Laboratory Animal Production Center
(CENPALAB), were immunized subcutaneously
with 217 μg of purified Erns each one. The
protein was previously diluted until the urea
decreased from 8 M to 2 M, to avoid toxic effects
for immunized animals. For the first dose, the
antigen was emulsified with a 1:1 ratio in
complete Freund's adjuvant (CFA). Six
subsequent immunizations were performed every
28 days; the first two with 100 μg and the rest
with 50 μg of antigen emulsified with a 1:1 ratio
in incomplete Freund's adjuvant (IFA). Blood
samples were taken by puncture of the ear vein to
sera titration. At the end of the immunization
scheme, exsanguination was performed by
cardiac puncture. Collected blood was incubated
for 30 min at 37°C and then for 30 min at 4°C.
The serum was extracted by centrifugation at
600 x g during 20 min. Animal experiments were
carried out in accordance with the legal
requirements of the national authorities.
Purification of polyclonal anti-Erns
antibody
A volume of 10 mL of immunized rabbit
serum was filtered through glass wool and
precipitated by 50 % (w/v) of (NH4)2SO4. The
resulting pellet was resuspended into 3 volumes
of binding buffer (1.5 M Glycine, 3 M NaCl, pH
8.9) and charged to an nProtein A Sepharose Fast
Flow (GE Healthcare) matrix packaged in a
C10/10 column (GE Healthcare) with a height of
8.5 cm and equilibrated with the same buffer.
Elution was performed at acidic pH with 0.1 M
citrate buffer pH 3.0. The flow was kept constant
at 0.6 mL/min throughout the process. The
chromatographic profile was monitored by
measuring absorbance at 280 nm. The eluate was
neutralized with 2 M Tris-HCl and dialyzed on
20 mM Tris-HCl, 150 mM NaCl pH 7 for 16 h,
and then it was filtered by 0.2 μm membranes.
Thimerosal was added as a preservative at a final
concentration of 0.02 % (v/v). The purity was
evaluated by SDS-PAGE under reducing
conditions, and the protein concentration was
determined by Lowry´s method using bovine
serum albumin as standard (9).
ELISA
Immunoenzymatic assays were performed on a
96-well polystyrene microtiter plate (Greiner,
Microlon, and High Binding Germany). The
coating was performed in 0.1 M carbonate buffer
pH 9.5 during 1h at 37°C with purified Erns
(10 µg/mL) in titration ELISAs and anti-Erns
polyclonal antibody in all antigen capture
ELISAs. In blocking step, skimmed milk powder
3 % (Oxoid, UK) (w/v) in PBS was used for 1 h
at 37°C. In the case of the conjugate in indirect
ELISA, an anti-rabbit IgG antibody coupled to
peroxidase produced in sheep was used,
according to the supplier (CIGBSS, Cuba). In the
direct ELISAs, the obtained polyclonal antibody,
conjugated to peroxidase, was used. All washing
steps were performed with wash solution (50 mM
Tris, 140 mM NaCl, 0.05 % Tween 20). Dilutions
of the samples and antibodies were performed in
a 1 % (w/v) skimmed milk powder solution in
PBS buffer, and incubations were performed at
37°C in a wet chamber. In all assays 100 μL were
added per well except the blocking step which
was carried out with 300 μL. The revealed
reaction was developed with a solution of Ortho-
phenylenediamine (0.5 mg/mL, dissolved in
0.0243 M citric acid with 0.0514 M disodium
hydrogen phosphate and 0.015 % hydrogen
peroxide). The development time was of
15 minutes in all cases and reaction was stopped
with 2 M H2SO4. The reading was carried out at
492 nm in a plate reader (Multiskan Titertek).
Conjugation of anti-Erns polyclonal
antibody to horseradish peroxidase
Conjugation was performed by the periodate
method (10). Briefly, 1 mL of purified antibody
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(8 mg/mL) in carbonate buffer 10 mM (pH 9.5)
was added to the activated enzyme and it was put
on the stirrer for 2h at 25ºC. Then, 0.4 mg of
sodium borohydride was added to the conjugated
solution. Precipitation by ammonium sulfate was
carried out and pellet was resuspended in
1.5 volumes of PBS. The conjugated solution was
dialyzed in PBS buffer, and bovine serum
albumin (BSA) was added at a concentration of
10 mg/mL. After BSA was completely hydrated,
an equal volume of 99 % glycerol was added
along with thimerosal solution to a final
concentration of 0.01 %.
RESULTS AND DISCUSSION
Antibodies against CSF markers, like Erns
protein, are vital for tests based on antigen
capture such as antigen capture ELISAs. An
important step for this type of ELISA is to ensure
biological reagents (antibodies) with high purity
to avoid unexpected results in the test.
Purification of the polyclonal anti-Erns
antibody from the sera of the immunized
rabbits
In order to clarify the serum, it was filtered by
glass wool to contribute to delipidation and avoid
unwanted interactions with the matrix. The
purification of anti-Erns antibodies was carried
out by Protein A affinity chromatography. An
eluate with 32 mg of total IgG (4 mg of IgG/mL
of Protein A matrix) was collected with purity
higher than 90 %. One of the most frequent
contaminants in antibody purification is albumin,
due to its high concentration in animal sera. In
order to eliminate part of the total albumin into
the clarified serum, it was precipitated with
ammonium sulfate. Regarding the chromatogram
of the process (Fig. 1A), it could be seen that the
peak of the elution corresponded to a high purity
fraction of the polyclonal antibody (Fig. 1B). The
absorbance corresponding to the non-absorbed
fraction indicated that the clarification of the
serum with glass wool and the ammonium sulfate
precipitation contributed to the purity of eluted
antibody as they prevented the overloading of the
matrix. However, a band of approximately
70 kDa was observed in the not-bound fraction
corresponding to albumin, which gave an idea of
its high amounts in serum. (Figure 1B).
Specificity and cross-reactivity of the anti-
Erns polyclonal antibody
To determine the reactivity of the purified
polyclonal antibody with the corresponding
protein, a western blot assay was performed
using the previously purified protein. The
Figure 1. Chromatogram (A) and 12 % polyacrylamide denaturing gel electrophoresis (B) of Protein A
affinity purification of rabbit anti-Erns polyclonal antibody. NB: proteins that not stick to the matrix. E: antibody
elution at pH 3. SMW: standard molecular weight Pre-stained SDS PAGE Standard Broad range- Biorad. S:
Rabbit serum immunized with Erns. E: elution at pH3 of Protein A sepharose matrix (polyclonal anti-Erns
antibody). MAb: anti-IL2h monoclonal antibody used as control / Cromatograma (A) y electroforesis en gel
desnaturalizado de poliacrilamida al 12% (B) de la proteína A, purificación de la afinidad del anticuerpo
policlonal anti-Erns de conejo. NB: proteínas que no se adhieren a la matriz. E: elución de anticuerpos a pH 3.
SMW: peso molecular estándar Pre-teñido SDS PAGE Estándar de amplio rango- Biorad. S: suero de conejo
inmunizado con Erns. E: elución a pH 3 de la matriz de la proteína A sefarosa (anticuerpo policlonal anti-Erns).
MAb: anticuerpo monoclonal anti-LI2h usado como control.
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antibody could recognize a band of
approximately 19 kDa, corresponding to the
truncated Erns (Fig. 2B). This implied that the
immunization procedure was efficient.
The reactivity of the antibody against other
unrelated proteins was assessed by an indirect
ELISA (Fig. 2A). The antibody showed no
reactivity against any of the adjuvants used in
immunization (complete and incomplete Freund's
adjuvants). As unrelated protein, the recombinant
p24 (belonging to the human immunodeficiency
virus) was used. This protein had a 6 histidine tag
as well as the truncated Erns used in
immunization. No reaction indicated that there
were not antibodies in the serum capable of
recognizing this fragment used in the production
of chimeric proteins. Another negative control
used was the extract of Escherichia coli BL21-
DE3 transformed with the PET-22 plasmid, but
without the insert containing the sequence
encoding the truncated Erns.
The reactivity of the antibody was observed
against proteins of the strain used for the
production of the antigen. However, the antibody
(10 μg/mL) had a 5-fold higher affinity for the
truncated Erns than for E. coli contaminants and
the monoclonal antibody evaluated as unrelated
protein. Besides, upon dilution of the antibody up
to 1250 ng/mL, the corresponding absorbance
was greater than 1 and no cross-reactivity was
observed at this concentration. This cross-
reactivity was attributed to small concentrations
of contaminants that may have been more
immunogenic than the truncated Erns, but also
other interactions (not antigen-antibody) could
have influenced the assay.
Conjugation of the anti-Erns polyclonal
antibody to horseradish peroxidase
In order to reduce the incubation steps in the
immuno-enzymatic assays for Erns detection, the
antibody was conjugated to peroxidase. Direct
ELISA was developed with coated Erns
(10 μg/mL) to evaluate working dilution. The
antibody was added at an initial dilution of 1:500
and serial 1:2 dilutions were performed. The
optimal dilution work was taken when the
observed absorbance was approximately 1
because with it, the signal over-saturation would
Figure 2. A: ELISA to evaluate the titer of anti-Erns polyclonal antibody purified by protein A. Erns: Coating
with truncated Erns (10 μg/mL). Sk: Coating with anti-streptokinase monoclonal antibody (10 μg/mL). P24:
Coating with recombinant p24-His protein from Human Immunodeficiency Virus. CFA: Coating with complete
Freund's adjuvant 1: 100 (v/v). IFA: Coating with incomplete Freund's adjuvant 1: 100 (v/v). E. coli: Coating
with E. coli BL21-DE3 (transformed with plasmid PET22b) protein extract, approximately 10 μg/mL calculated
from the estimation that 16 % of the E. coli wet weight biomass is protein. B: Western blot performed to assess
specificity of the polyclonal antibody with the truncated Erns. Et: 5μg of Erns truncated. SMW: Pre-stained SDS
PAGE -Biorad standard molecular weight. / ELISA para evaluar el título del anticuerpo policlonal anti-Erns
purificado por la proteína A. Erns: recubrimiento con Erns truncado (10 μg/mL). Sk: recubrimiento con
anticuerpo monoclonal anti-estreptoquinasa (10 μg/mL). P24: recubrimiento con la proteína recombinante p24-
H de su virus de inmunodeficiencia humana. CFA: recubrimiento con el adyuvante completo de Freund 1: 100
(v/v). IFA: recubrimiento con el adyuvante incompleto de Freund 1: 100 (v/v). E. coli: recubrimiento con
extracto de proteína E. coli BL21-DE3 (transformada con el plásmido PET22b), aproximadamente 10 μg/mL
calculado a partir de la estimación de que el 16% de la biomasa de peso húmedo de E. coli era proteína. B:
Western blot realizado para evaluar la especificidad del anticuerpo policlonal con la Erns truncada. Et: 5μg de
Erns truncado. SMW: Pre-teñido SDS PAGE -Biorad peso molecular estándar.
Revista de Salud Animal, Vol. 41, No. 3, september-december  2019, E-ISSN: 2224-4700
 5
be avoided in the plate reader. As shown in
Figure 3, absorbance was about 1 with a dilution
of 1: 64000, so this could be taken as working
dilution. This conjugated antibody could also be
used in other assays such as western blot and dot-
blot, but for these kinds of assays, the optimal
dilution and substrate conditions must have been
established to ensure the best performance for
each technique.
Coating antibody concentration
Four coating concentrations were evaluated
with the antibody to determine the optimal
capture conditions. Eight dilutions of the used
samples were evaluated: purified recombinant
Erns as positive control, P24 as a negative control
and a mixture of sera from healthy pigs to
evaluate the possible recognition of nonspecific
proteins in sera (Fig. 4). The assay demonstrated
that coating at 10 μg/ mL was the condition at
which higher Erns was captured. It was also
observed that the antibody did not capture
proteins from healthy pig sera.
Viral Erns capture in pig sera
The best coating concentration (10 µg/mL)
was used in a Sandwich ELISA (Fig. 5). The
polyclonal antibody could recognize Erns from
the sera of individual animals positive to CSFV
and from a pool of sera which belonged to the
animals vaccinated with the Chinese strain of
CSFV. Other authors have also detected viral
Erns in sandwich ELISA for the diagnosis of
CSF and they have obtained successful results
when compared with more specific techniques
such as RT-PCR (5). Nevertheless, in some cases,
good results have not been obtained with the
antigen-capture ELISAs for the diagnosis of CSF
(4).
Negative samples (serum from animals
vaccinated with Porvac®) were evaluated in the
same ELISA. The fact that it did not recognize
negative sera, including healthy animals
immunized with E2, supported the hypothesis
that the antibody could be a useful tool to
distinguish vaccinated animals from those
infected with CSFV. Besides, the development of
an antigen capture technique by ELISA could
work like a complement in the diagnosis of CSF
in passively immunized animals and in
persistently infected pigs a few days after birth
with moderately virulent strains of CSFV that did
not rise up an immune response. Unlike the direct
ELISA, where the antibody detected E. coli
BL21DE3-Pet22b proteins coated at 10 μg/mL
(Fig. 2A), this non-specific reactivity was not
observed in the sandwich ELISA. In addition,
there was no response against the sera from
animals immunized with E2.
Figure 3. Direct ELISA to evaluate the titer of the antibody conjugated to horseradish peroxidase.
In dark, the optimal work dilution of antibody for this assay. / ELISA directo para evaluar el título del
anticuerpo conjugado con peroxidasa de rábano picante. En la oscuridad, la dilución óptima del
anticuerpo en el trabajo para este ensayo
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Figure 4. Sandwich ELISA with anti-Erns polyclonal antibody as capture and the same conjugated
antibody for developing. Coating concentrations with antibody 1 (▪▪▪), 2 (▬ ▪ ▬) 5 (▬ ▬) and 10
(▬▬) μg/mL. Samples of Erns (♦), p24 (Δ) and negative sera (□) were used. Eight serial dilutions of
1: 2 were made to all samples. In the case of Erns and p24, 1 μg/mL was started. / ELISA sándwich
con anticuerpo policlonal anti-Erns como captura y el mismo anticuerpo conjugado para el
desarrollo. Concentraciones de recubrimiento con el anticuerpo 1 (▪▪▪), 2 (▬ ▪ ▬) 5 (▬ ▬), y 10
(▬▬) μg/mL. Se utilizaron muestras de Erns (♦), p24 (Δ) y sueros negativos (□). Se hicieron ocho
diluciones en serie de 1: 2 a todas las muestras. En el caso de la Erns y la p24, se inició 1 μg/mL.
Figure 5. Sandwich ELISA developed to evaluate the recognition of Erns in a pool of positive pig
sera and individual positive sera. In the case of serum samples, dilutions of 1: 2 (v/v) were started.
Eight serial dilutions of 1: 2 were made to all samples. In the case of Erns and the E. coli BL21-
pET22b protein extract, 1 μg / mL was started. Erns curve (■), Pool of positive sera (♦), Individual
sera of vaccinated animals with the Chinese strain (×), Negative serum (○), E. coli-pET22b protein
extract (∆), Serum of animals immunized with a DIVA vaccine based on E2 glycoprotein (●). / ELISA
sándwich desarrollado para evaluar el reconocimiento de Erns en un conjunto de sueros de cerdo
positivos y sueros positivos individuales. En el caso de las muestras de suero, se iniciaron diluciones
de 1: 2 (v/v). Se hicieron ocho diluciones seriadas de 1: 2 en todas las muestras. En el caso de Erns y
el extracto de proteína E. coli BL21-pET22b, se inició 1 μg / mL. Curva de Erns (■), Pool de sueros
positivos (♦), Sueros individuales de animales vacunados con la cepa china (×), Suero negativo (○),
Extracto de proteína E. coli-pET22b (∆), Suero de animales inmunizados con una vacuna DIVA
basada en la glicoproteína E2 (●).
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CONCLUSIONS
In this work, a rabbit anti-Erns polyclonal
antibody, which recognized specifically the
recombinant protein Erns used in the
immunization scheme, was obtained. It was also
able to conjugate the antibody to horseradish
peroxidase, and the working dilution of the
conjugate in a direct ELISA was 1:64000. A
sandwich ELISA was performed with the
polyclonal antibody to capture native Erns from
vaccinated pig sera with the Chinese strain, and it
was able to detect signals in those animals
immunized with this vaccine, showing that the
antibody could be used as a tool for CSF
diagnosis.
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